CEO stock sale

Iradimed CEO sells $694K in shares via pre-planned strategy while retaining 4M+ shares. Strong 78% stock gain reflects 14% revenue growth, but 42x forward P/E suggests patience before buying.

Vir Biotechnology CEO Marianne De Backer sold 72,559 shares worth $664,350, representing 6.76% of holdings. Sale aligns with historical patterns amid company's positive momentum.

Beam Therapeutics CEO John Evans sold 30,078 shares for $739K via pre-planned tax obligation. Strong 2025 revenue growth and $1.2B cash reserves indicate company health.

Pitney Bowes CEO sells $2.2M in stock via pre-planned transaction while retaining 8M shares, as company posts $145M profit swing and 24% free cash flow growth despite 7% revenue decline.

$FLO CEO sells $1.68M in shares amid $67.1M fiscal loss, raising investor concerns despite maintaining substantial stake.

Century Aluminum CEO sells $8.3M in shares as aluminum prices hit 4-year highs, leveraging pre-arranged trading plan amid geopolitical supply disruptions.

Fastly CEO sells $1.2M in stock via pre-planned trading program. Stock surged 265.5% on AI boom but trades at multi-year valuation high.

$YUMC CEO Joey Wat sells 104,000 shares worth $5.74M in first recorded divestiture, holding 12.84% less of company despite 12% stock gains.

UWMC CEO Mat Ishbia sold 1.9M shares for $9M, cutting his holdings nearly in half. The pre-arranged sale reflects ongoing pressure on the mortgage lender's stock.

Novanta CEO sells shares in routine plan sale. Stock up 23% YTD with strong growth, but elevated valuation concerns limit upside potential.

SentinelOne CEO sold $532K in shares via pre-arranged plan amid 43% stock decline. Stock trades at attractive valuations as company approaches $1B revenue milestone.

Intuitive Machines CEO sold $1.4M in stock for tax purposes. Despite new Air Force contracts, the company remains unprofitable with declining revenue.